Current dosing practices for immunoglobulin G (IgG) may be inadequate in extreme body weight.
The current study will evaluate the influence of body composition on intravenous and
subcutaneous administration of immunoglobulin G in patients.
Phase:
Phase 1
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Treatments:
Antibodies gamma-Globulins Immunoglobulin G Immunoglobulins Immunoglobulins, Intravenous Rho(D) Immune Globulin